Default company panoramic image
Aq 20biomed 20logo

AQ BioMed

Based on years of grant-funded R&D and protected by 6 issued and 2 pending patents, the AQ Shunt competes in the growing $5B surgical glaucoma treatment market.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Boulder, CO, US
  • Currency USD
  • Founded July 2015
  • Employees 1
  • Incorporation Type C-corp
  • Website aqbiomed.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.